ECC 2015 Press Release: Results of International Trial Show Promise in Rare, Difficult to Treat Cancer: results from the RADIANT-4 trial


An international team of researchers has shown that the use of the mTOR inhibitor everolimus can delay tumour growth among both gastrointestinal and lung NETs

No relation
27/09/2015 1:31 pm
There are no related objects.